Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

Abstract Background Predicting the clinical course of prostate cancer is challenging due to the wide biological spectrum of the disease. The objective of our study was to identify prostate cancer prognostic markers in patients ‘sera using a multi-omics discovery platform. Methods Pre-surgical serum...

Full description

Bibliographic Details
Main Authors: Michael A. Kiebish, Jennifer Cullen, Prachi Mishra, Amina Ali, Eric Milliman, Leonardo O. Rodrigues, Emily Y. Chen, Vladimir Tolstikov, Lixia Zhang, Kiki Panagopoulos, Punit Shah, Yongmei Chen, Gyorgy Petrovics, Inger L. Rosner, Isabell A. Sesterhenn, David G. McLeod, Elder Granger, Rangaprasad Sarangarajan, Viatcheslav Akmaev, Alagarsamy Srinivasan, Shiv Srivastava, Niven R. Narain, Albert Dobi
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Journal of Translational Medicine
Subjects:
Bayesian networks
Biochemical recurrence
Biomarkers
Metabolomics
Prostate cancer
Online Access:https://doi.org/10.1186/s12967-019-02185-y

Internet

https://doi.org/10.1186/s12967-019-02185-y

Similar Items